(Q53073221)

English

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).

scientific article published in April 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

1 reference

based on heuristic

inferred from title

author name string

R T Morris

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

R N Joyrich

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

R W Naumann

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

N P Shah

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

A H Maurer

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

H W Strauss

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

J M Uszler

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

J T Symanowski

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

P R Ellis

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

W A Harb

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

25

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

852-858

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Exploitation of the folate receptor in the management of cancer and inflammatory disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU024

21 January 2018

Identifiers

10.1093/ANNONC/MDU024

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53073221&oldid=1800762773"